What is postpartum thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postpartum Thyroiditis Overview

Postpartum thyroiditis is a transient autoimmune thyroid disorder occurring within the first year after delivery, characterized by sequential or isolated phases of hyperthyroidism and/or hypothyroidism, with most women returning to euthyroid status by 12 months postpartum. 1, 2, 3

Epidemiology and Pathophysiology

  • The prevalence ranges from 5-9% in the general population, with a mean of 7.5% across studies 3, 4
  • Women with type 1 diabetes mellitus have a three-fold increased risk 3
  • This condition represents an autoimmune flare following the immune suppression of pregnancy, essentially a transient form of Hashimoto's thyroiditis 3, 5
  • Up to 50% of women who are thyroid peroxidase antibody (TPO-Ab) positive in the first trimester will develop postpartum thyroiditis 4

Clinical Presentation Patterns

The classic triphasic pattern occurs in only 22% of cases 4:

  • Isolated hypothyroid phase: 48% of cases 4
  • Isolated thyrotoxic phase: 30% of cases 4
  • Sequential hyperthyroidism followed by hypothyroidism: 22% of cases 4

Timing of Phases

  • Hyperthyroid phase typically occurs around 14 weeks postpartum 6
  • Hypothyroid phase typically occurs around 19 weeks postpartum 6

Symptomatology

Hyperthyroid phase symptoms:

  • Lack of energy and irritability are most common 6

Hypothyroid phase symptoms (more symptomatic than hyperthyroid phase):

  • Fatigue, dry skin, impaired memory, aches and pains, and cold intolerance 6, 4

Critical pitfall: Many of these symptoms overlap with normal postpartum experiences, making clinical diagnosis challenging without objective testing 2

Diagnostic Approach

Diagnosis is established by new onset of abnormal TSH level, abnormal free T4 level, or both within one year of delivery 1, 2

Who to Evaluate

  • Women who develop a goiter during pregnancy or after delivery 1, 2
  • Women with postpartum symptoms of hyperthyroidism or hypothyroidism (requires clinical judgment given symptom overlap with normal postpartum period) 1, 2
  • Women with a history of thyroid disease 1

Confirmatory Testing

  • Thyroid peroxidase antibodies (TPO-Ab) are useful for confirming the diagnosis 1, 2
  • The presence of positive TPO-Ab differentiates postpartum thyroiditis from other conditions 7
  • Thyroid ultrasound may show diffuse or multifocal hypoechogenicity 6

Treatment Algorithm

Hyperthyroid (Thyrotoxic) Phase

  • Beta-blockers for symptomatic control when required (short course) 3, 4
  • Antithyroid drugs are NOT indicated as this represents thyroid destruction, not overproduction 4
  • Monitor thyroid function every 2-3 weeks to detect transition to hypothyroidism 2

Hypothyroid Phase

Treatment indications based on TSH levels:

  • TSH >10 mIU/L: Levothyroxine replacement is indicated 2
  • TSH 4-10 mIU/L: Consider levothyroxine if patient is symptomatic or desires fertility 2
  • Adjust levothyroxine dosage to normalize TSH 2

Additional treatment considerations:

  • Treatment is indicated for symptomatic relief in breastfeeding women or those attempting to conceive 4
  • Objective thyroid function testing should guide treatment decisions rather than symptoms alone due to overlap with normal postpartum symptoms 2

Long-Term Prognosis and Follow-Up

Risk of Permanent Hypothyroidism

  • Approximately 25-30% of women develop permanent hypothyroidism within 3 years 3, 6
  • Up to 50% will be hypothyroid at 7-9 years of follow-up 6
  • The risk is greatest in women with the highest TSH levels and highest antithyroid peroxidase antibody titers 1, 2
  • Women who remain euthyroid postpartum despite positive TPO-Ab have only a 5% long-term risk 6

Recurrence Risk

  • 70% recurrence rate in subsequent pregnancies if previous postpartum thyroiditis occurred 6
  • 25% risk if the patient was euthyroid after the first pregnancy 6

Key Clinical Pitfalls

  • Postpartum thyroiditis is characteristically painless, distinguishing it from subacute thyroiditis which presents with painful thyroid and pharyngeal pain 7
  • Do not rely on symptoms alone for diagnosis or treatment decisions given significant overlap with normal postpartum experiences 2
  • Long-term follow-up is essential as this is not a benign, self-limited condition—it carries significant risk of permanent hypothyroidism and potential cardiovascular consequences 5
  • Women with preexisting Hashimoto's thyroiditis can still develop postpartum thyroiditis patterns, particularly if euthyroid in the first trimester 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Postpartum Thyroiditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Postpartum thyroiditis.

Best practice & research. Clinical endocrinology & metabolism, 2004

Research

Approach to the patient with postpartum thyroiditis.

The Journal of clinical endocrinology and metabolism, 2012

Research

Clinical manifestations of postpartum thyroid disease.

Thyroid : official journal of the American Thyroid Association, 1999

Guideline

Subacute Thyroiditis: Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.